MYELOID SARCOMA OF THE ILEUM: CASE REPORT OF A PATIENT WITHOUT BONE MARROW INVOLVEMENT
Sarcoma mieloide en íleon: reporte de caso en una paciente sin afectación medular
DOI:
https://doi.org/10.59420/remus.9.2023.155Keywords:
acute myeloid leukemia, extramedullary myeloid leukemia, granulocytic sarcomaAbstract
Myeloid sarcoma consists of the extramedullary proliferation of blasts which include one or more myeloid lineages. It is an extremely rare neoplasm, with an incidence of 2 cases per million inhabitants in the adult population. This disease can precede, coexist, or occur after an initial diagnosis of acute myeloid leukemia, which the most frequent form. We present the case of a 30-year-old woman who had been diagnosed with extramedullary myeloid sarcoma in the ileum without blasts infiltration into the bone marrow, which was proven by biopsy. The disease started with abdominal pain in May 2022, after the diagnosis she had an ileum resection performed and started with chemotherapy. At the moment she’s in complete remission as shown by positron emission tomography and she’s on midostaurin maintenance. The approach of the current case of isolated myeloid sarcoma has great value for research, since in addition of being a pathology described in few case reports, the location of the sarcoma in the patient makes it an even more unusual condition, making its description a key piece for the evolution in medical knowledge.
Downloads
References
Zhao H, Dong Z, Wan D, Cao W, Xing H, Liu Z et al. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Sci Rep. 2022; 12(1):6752. Disponible en: http://dx.doi.org/10.1038/s41598-022-10831-7
Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2021; 2(5):309–16. Disponible en: http://dx.doi. org/10.1177/2040620711410774
Meyer H-J, Pönisch W, Schmidt SA, Wienbeck S, Braulke F, Schramm D et al. Clinical and imaging features of myeloid sarcoma: a German multicenter study. BMC Cancer. 2019; 19(1). Disponible en: http://dx.doi. org/10.1186/s12885-019-6357-y
Stefanidakis M, Karjalainen K, Jaalouk DE, Gahmberg CG, O’Brien S, Pasqualini R et al. Role of leukemia cell invadosome in extramedullary infiltration. Blood. 2019; 114(14):3008–17. Disponible en: http://dx.doi.org/10.1182/blood-2008-04-148643
Wang C, Chen Z, Li Z, Cen J. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res. 2010; 34(8):1083–90. Disponible en: http://dx.doi.org/10.1016/j.leukres.2010.01.016
Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011; 118(14):3785–93. Disponible en: http://dx.doi.org/10.1182/blood-2011-04-347229
Zhao H, Dong Z, Wan D, Cao W, Xing H, Liu Z et al. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Sci Rep. 2022; 12(1):6752. Disponible en: http://dx.doi.org/10.1038/s41598-022-10831-7
Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid sarcoma. Oncol Res Treat. 2019; 42(4):224–9. Disponible en: http://dx.doi.org/10.1159/000497210
Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011; 118(14):3785–93. Disponible en: http://dx.doi.org/10.1182/blood-2011-04-347229
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora (Journal of Medical Students' of the University of Sonora)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
